SIRT7-mediated deacetylation of XRCC6 at lysine 591 drives breast cancer progression - Top-Institutions - MDSpire

SIRT7-mediated deacetylation of XRCC6 at lysine 591 drives breast cancer progression

  • By

  • Jie Yin

  • Jiaxing Liu

  • Meirui He

  • Tang Xiao

  • Wenjuan Xiang

  • Ruxia Sheng

  • Haifang Zhao

  • Xinyue Huang

  • Sheng Xu

  • Yong Zhou

  • Junfeng Liu

  • Ruijuan Heng

  • Xiaoying He

  • Yunxiang Wang

  • Yu Song

  • Pan Qi

  • May 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #3

    The Wistar Institute
    The Wistar Institute

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology
    • Cancer Research

Original Source(s)

SIRT7-mediated deacetylation of XRCC6 at lysine 591 drives breast cancer progression

  • by Jie Yin, Jiaxing Liu, Meirui He, Tang Xiao, Wenjuan Xiang, Ruxia Sheng, Haifang Zhao, Xinyue Huang, Sheng Xu, Yong Zhou, Junfeng Liu, Ruijuan Heng, Xiaoying He, Yunxiang Wang, Yu Song, Pan Qi

  • May 8, 2026

Related Content

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation